X4 Pharmaceuticals Inc. (XFOR)
NASDAQ: XFOR
· Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT
X4 Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 32.77M | 31.36M | 2.56M | 4.18M | 3.62M | 3.06M | 3.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 5.57M | 5.51M | 859K | 619K | 894K | 1.14M | 1.59M | 2.03M | 2.02M | 2.01M | 1.99M | 1.99M | 1.98M | 1.97M | 1.89M | 1.4M | 907K | 420K |
Gross Profit | 27.2M | 25.85M | 1.7M | 3.56M | 2.73M | 1.92M | 1.47M | -2.03M | -2.02M | -2.01M | -1.99M | -1.99M | -1.98M | -1.97M | -1.89M | -1.4M | -907K | -420K |
Operating Income | -105.89M | -8.55M | -36.4M | -25.89M | -18.6M | -115.51M | -104.02M | -101.73M | -100.09M | -94.86M | -90.32M | -96.47M | -90.01M | -88.44M | -85.11M | -73.71M | -71.57M | -67.23M |
Interest Income | 4.83M | 5.73M | 5.77M | 5.95M | 5.46M | 4.81M | 4.58M | 3.33M | 1.96M | 1.05M | 219K | 24K | 12K | 11K | 10K | 8K | 6K | 10K |
Pretax Income | -101.63M | 14.92M | -37.14M | -16.67M | 17.73M | -128.82M | -132.77M | -137.69M | -164.5M | -130.01M | -96.26M | -102.44M | -93.53M | -91.95M | -88.68M | -76.88M | -74.15M | -69.66M |
Net Income | -101.98M | 14.6M | -37.45M | -16.76M | 17.63M | -128.91M | -132.86M | -137.75M | -164.55M | -130.05M | -96.3M | -102.49M | -93.56M | -91.98M | -88.7M | -76.89M | -74.16M | -69.67M |
Selling & General & Admin | 55.35M | 59.1M | 61.52M | 56.3M | 48.77M | 45.7M | 38.47M | 35.78M | 34.21M | 30.76M | 28.22M | 28.11M | 27.48M | 26.53M | 24.7M | 22.92M | 22.59M | 22.1M |
Research & Development | 77.74M | 80.3M | 81.58M | 75.09M | 75M | 69.68M | 65.49M | 72.35M | 72.28M | 70.5M | 69.01M | 59.11M | 53.28M | 52.66M | 50.65M | 50.78M | 48.98M | 45.13M |
Other Expenses | n/a | -105M | -105M | -105M | -105M | -29.89M | -59.78M | -54.5M | -58.01M | -28.18M | 1.78M | -4.66M | -1.22M | -1.8M | -1.67M | -523K | -449K | 186K |
Operating Expenses | 133.09M | 34.41M | 38.1M | 26.39M | 18.77M | 115.38M | 103.96M | 108.13M | 106.49M | 101.26M | 97.23M | 87.22M | 80.76M | 79.19M | 75.35M | 73.71M | 71.57M | 67.23M |
Interest Expense | 9.15M | 9.1M | 8.77M | 8.35M | 7.57M | 6.54M | 5.78M | 5.04M | 4.42M | 4.19M | 3.99M | 3.77M | 3.68M | 3.66M | 3.64M | 3.44M | 3.21M | 3M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.17M | -15.02M | -15.02M | -15.02M | -7.85M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 138.66M | 39.92M | 38.96M | 27.01M | 19.16M | 115.51M | 104.02M | 108.13M | 106.49M | 101.26M | 97.23M | 87.22M | 80.76M | 79.19M | 75.35M | 73.71M | 71.57M | 67.23M |
Income Tax Expense | 344K | 325K | 310K | 85K | 96K | 93K | 89K | 60K | 48K | 37K | 45K | 44K | 32K | 34K | 17K | 14K | 12K | -60K |
Shares Outstanding (Basic) | 7.41M | 6.84M | 6.7M | 6.7M | 6.73M | 6.67M | 6.63M | 6.57M | 5.62M | 4.87M | 3.36M | 2.74M | 1.18M | 1.02M | 813.43K | 886.97K | 884.23K | 691.7K |
Shares Outstanding (Diluted) | 7.41M | 6.87M | 6.7M | 6.7M | 6.69M | 6.67M | 6.63M | 6.57M | 5.62M | 4.87M | 3.36M | 2.77M | 1.18M | 1.12M | 967.03K | 886.97K | 884.23K | 691.7K |
EPS (Basic) | -14.83 | 396.64 | 388.80 | 391.91 | 396.96 | -20.94 | -17.94 | -23.75 | -31.2 | -39.3 | -56.1 | -84.6 | -99.6 | -103.8 | -121.2 | -111.3 | -114.6 | -115.2 |
EPS (Diluted) | -14.83 | 393.64 | 385.80 | 388.91 | 393.96 | -20.94 | -17.94 | -23.75 | -31.2 | -39.3 | -56.1 | -84.6 | -99.6 | -103.8 | -121.2 | -111.3 | -114.6 | -115.2 |
EBITDA | -94.22M | -101.7M | -154.5M | -134.66M | -100.81M | -121.14M | -93.72M | -104.02M | -124.03M | -89.78M | -87.92M | -89.26M | -88.16M | -86.61M | -83.44M | -72.21M | -69.98M | -66.14M |
EBIT | -92.48M | -102.91M | -155.3M | -135.25M | -101.63M | -122.28M | -95.31M | -106.05M | -125.98M | -91.72M | -89.85M | -91.18M | -89.85M | -88.29M | -85.04M | -73.44M | -70.94M | -66.67M |
Depreciation & Amortization | 1.02M | 1.21M | 796K | 585K | 820K | 1.14M | 1.59M | 2.03M | 2.02M | 2.01M | 1.99M | 1.99M | 1.98M | 1.97M | 1.89M | 1.5M | 1.16M | 735K |